Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma

Journal of Asthma and Allergy

Volumn 3, Issue , 2010, Pages 101-106

  Vaidya, Varun ^a   Holiday Goodman, Monica ^a   Pinto, Sharrel ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Asthma; Demographics; Inhaled corticosteroids

Indexed keywords

EID: 84860665880     PISSN: 11786965     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S11683     Document Type: Article

References (17)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-478.
2. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24.
3. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;1205 Suppl: S94-S138.
4. Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma. 2005;42(7):529-535.
5. Smith LA, Bokhour B, Hohman KH, et al. Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma. Pediatrics. 2008;122(4):760-769.
6. Anis AH, Lynd LD, Wang XH, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ. 2001;164(5):625-631.
7. Panettieri RA Jr, Spector SL, Tringale M, Mintz ML. Patients’ and primary care physicians’ beliefs about asthma control and risk. Allergy Asthma Proc. 2009;30(5):519-528.
8. Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141(2):189-198.
9. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156(3 Pt 1):787-793.
10. Stroupe KT, Gaskins D, Murray MD. Health-care costs of inner-city patients with asthma. J Asthma. 1999;36(8):645-655.
11. National Asthma Survey 2004. Available from: http://www.cdc.gov/nchs/slaits/nas.htm. Accessed Nov 14, 2009.
12. The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 3rd ed. Lenexa, Kansas: AAPOR; 2004.
13. Colice G, Wu EQ, Birnbaum H, Daher M, Maryna BM. Use of inhaled corticosteroids and healthcare costs in mild persistent asthma. J Asthma. 2007;44(6):479-483.
14. Stingone JA, Claudio L. Components of recommended asthma care and the use of long-term control medication among urban children with asthma. Med Care. 2009;47(9):940-947.
15. Weiss KB. An action agenda to eliminate asthma disparities: results from the workgroups of the National Workshop to Eliminate Asthma Disparities. Chest. 2007;132 Suppl 5:S853-S855.
16. Bryant-Stephens T. Asthma disparities in urban environments. J Allergy Clin Immunol. 2009;123(6):1199-1206; quiz 1207-1208.
17. La Roche MJ, Koinis-Mitchell D, Gualdron L. A culturally competent asthma management intervention: a randomized controlled pilot study. Ann Allergy Asthma Immunol. 2006;96(1):80-85.